Mirataz Transdermal Ointment 5 GM For Cats

• Mirataz is the first and only FDA-approved transdermal medication for the management of weight loss in cats
• In clinical studies, Mirataz resulted in significant weight gain in cats in as little as 14 days following topical application of 2 mg oer day8
• Mirataz gives your clients a practical way to manage their cat's weight loss without administration of oral medication and does not rely on the cat to eat to be medicated
• Due to proprietary Accusorb™ technology, Mirataz achieves measurable plasma concentrations of mirtazapine in cats9
• Mirataz was well tolerated both locally and systemically in clinical studies8

Administer topically by applying a 1.5-inch ribbon of ointment (approximately 2 mg/cat) on the inner pinna of the cat's ear once daily for 14 days (see Diagrams below).

Wear disposable gloves when applying Mirataz™ Dispose of used gloves after each application.

Alternate the daily application of Mirataz™ between the left and right inner pinna of the ears. Do not administer into the external ear canal. If desired, the inner pinna of the cat's ear may be cleaned by wiping with a dry tissue or cloth immediately before the next scheduled dose. If a dose is missed, apply Mirataz™ the following day and resume daily dosing.

To demonstrate the method of administering the dose, the veterinarian or trained personnel at the clinic should apply the first dose in the presence of the owner.

Mirtazapine